168 related articles for article (PubMed ID: 15604209)
41. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor Beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species.
Li WQ; Qureshi HY; Liacini A; Dehnade F; Zafarullah M
Free Radic Biol Med; 2004 Jul; 37(2):196-207. PubMed ID: 15203191
[TBL] [Abstract][Full Text] [Related]
43. miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.
Chuang TD; Luo X; Panda H; Chegini N
Mol Endocrinol; 2012 Jun; 26(6):1028-42. PubMed ID: 22556343
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
45. The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma.
Park JY; Chae B; Kim MR
Int J Med Sci; 2022; 19(12):1779-1786. PubMed ID: 36313223
[No Abstract] [Full Text] [Related]
46. Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells.
Kanai H; Tanaka T; Aihara Y; Takeda S; Kawabata M; Miyazono K; Nagai R; Kurabayashi M
Circ Res; 2001 Jan; 88(1):30-6. PubMed ID: 11139470
[TBL] [Abstract][Full Text] [Related]
47. Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells.
Xie S; Sukkar MB; Issa R; Oltmanns U; Nicholson AG; Chung KF
Am J Physiol Lung Cell Mol Physiol; 2005 Jan; 288(1):L68-76. PubMed ID: 15377500
[TBL] [Abstract][Full Text] [Related]
48. Differential expression of transforming growth factor-beta 1 and transforming growth factor-beta receptors in myometrium of women with failed induction of labor, no labor, and preterm labor.
Chegini N; Ma C; Davis J; Duff P; Rosa C
J Soc Gynecol Investig; 1999; 6(5):258-63. PubMed ID: 10554764
[TBL] [Abstract][Full Text] [Related]
49. Early growth response-2 expression in uterine leiomyoma cells: regulation and function.
Yin P; Navarro A; Fang F; Xie A; Coon JS; Richardson C; Bulun SE
Fertil Steril; 2011 Aug; 96(2):439-44. PubMed ID: 21703609
[TBL] [Abstract][Full Text] [Related]
50. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
Shen Y; Wu Y; Lu Q; Zhang P; Ren M
Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
[TBL] [Abstract][Full Text] [Related]
51. Amphotericin B-copper (II) complex alters transcriptional activity of genes encoding transforming growth factor-beta family members and related proteins in renal cells.
Gola J; Strzałka-Mrozik B; Wieczorek E; Kruszniewska-Rajs C; Adamska J; Gagoś M; Czernel G; Mazurek U
Pharmacol Rep; 2017 Dec; 69(6):1308-1314. PubMed ID: 29128814
[TBL] [Abstract][Full Text] [Related]
52. Concordant upregulation of type II-TGF-beta-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity.
Ihling C; Technau K; Gross V; Schulte-Mönting J; Zeiher AM; Schaefer HE
Atherosclerosis; 1999 May; 144(1):7-14. PubMed ID: 10381272
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of transforming growth factor-beta 1 alters the growth, anchor-dependent cell aggregation and integrin mRNA expression in human promonocytes: implications for endometriosis and peritoneal adhesion formation.
Dou Q; Williams RS; Chegini N
Mol Hum Reprod; 1997 May; 3(5):383-91. PubMed ID: 9239722
[TBL] [Abstract][Full Text] [Related]
54. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.
Kalembeyi I; Inada H; Nishiura R; Imanaka-Yoshida K; Sakakura T; Yoshida T
Int J Cancer; 2003 May; 105(1):53-60. PubMed ID: 12672030
[TBL] [Abstract][Full Text] [Related]
55. [Expression of cellular phenotype switching markers-matrix protein Gla, mRNA and collagen I, III and V of human airway smooth muscle cells in vitro after TGF-beta1 stimulation].
Shao J; Xia ZW; Li YZ; Yu SC; Deng WW
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):531-4. PubMed ID: 17044981
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
[TBL] [Abstract][Full Text] [Related]
57. Differentially regulated expression of neurokinin B (NKB)/NK3 receptor system in uterine leiomyomata.
Cañete H; Dorta I; Hernández M; Cejudo Roman A; Candenas L; Pinto FM; Valladares F; Báez D; Montes de Oca F; Bello AR; Almeida TA
Hum Reprod; 2013 Jul; 28(7):1799-808. PubMed ID: 23656837
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
Wolańska M; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
[TBL] [Abstract][Full Text] [Related]
59. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
60. Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms.
Lewis TD; Malik M; Britten J; Parikh T; Cox J; Catherino WH
Fertil Steril; 2019 Apr; 111(4):806-815.e1. PubMed ID: 30871768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
